Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-Label, Multicenter, First-in-Human, Dose-Escalation and Dose-Expansion, Phase 1/2 Study of BBI-355 and BBI-355 in Combination With Select Targeted Therapies in Subjects With Locally Advanced or Metastatic Solid Tumors With Oncogene Amplifications

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05827614
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:34.452555+00:00
Published At
2026-01-23T00:00:00+00:00
Record Updated At
2026-01-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Triple Negative Breast Cancer (TNBC)", "High Grade Serous Ovarian Carcinoma", "High Grade Endometrial Carcinoma", "Anogenital Cancer", "Head and Neck (HNSCC)", "Cutaneous Squamous Cell Carcinoma (CSCC)", "Cervical Squamous Cell Carcinoma", "ER+ Breast Cancer", "Leiomyosarcoma (LMS)", "Undifferentiated Pleomorphic Sarcoma (UPS)", "Pancreatic Cancer Metastatic", "Small Cell Lung Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-23"
protocolSection.identificationModule.nctId
"NCT05827614"
protocolSection.identificationModule.officialTitle
"An Open-Label, Multicenter, First-in-Human, Dose-Escalation and Dose-Expansion, Phase 1/2 Study of BBI-355 and BBI-355 in Combination With Select Targeted Therapies in Subjects With Locally Advanced or Metastatic Solid Tumors With Oncogene Amplifications"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Triple Negative Breast Cancer (TNBC) (protocolSection.conditionsModule.conditions)
  • High Grade Serous Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • High Grade Endometrial Carcinoma (protocolSection.conditionsModule.conditions)
  • Anogenital Cancer (protocolSection.conditionsModule.conditions)
  • Head and Neck (HNSCC) (protocolSection.conditionsModule.conditions)
  • Cutaneous Squamous Cell Carcinoma (CSCC) (protocolSection.conditionsModule.conditions)
  • Cervical Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • ER+ Breast Cancer (protocolSection.conditionsModule.conditions)
  • Leiomyosarcoma (LMS) (protocolSection.conditionsModule.conditions)
  • Undifferentiated Pleomorphic Sarcoma (UPS) (protocolSection.conditionsModule.conditions)
  • Pancreatic Cancer Metastatic (protocolSection.conditionsModule.conditions)
  • Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.